Aflatoxins
DOI:
https://doi.org/10.51481/amc.v46i4.157Keywords:
Aflatoxinas, Aspergillus flavus, Aspergillus parasiticus, carcinoma hepatocelu-lar, aflatoxicosis, teratógenos, virus de la hepatitis BAbstract
Micotoxins are chemical substances from toxin-pro-ducing fungal species, mainly Aspergillus flavusandAspergillus parasiticus. They can cause diseases and deathof animals and human beings.
Aflatoxins are micotoxins often isolated from peanuts,rice, corn or other edible seeds improperly handled afterharvest.
They can also be found in secretions or depositions ofanimals that commonly eat contaminated food.
Aflatoxin ingestion causes aflatoxicosis. B1aflatoxin is known to alter fetal development and is capableof inducing mutations of genes and cancer. It can specifical-ly induce a mutation of codon 249 of suppressor gene P53facilitating oncogenesis.
Downloads
References
Stein P, Vleggar R, Weassels P. The biosynthesis of aflatoxin and itscongeners. En P. S. Steyn, The biosynthesis of mycotoxins. NewYork: Academic Press 1980: 105-155.
Turner, W. Fungal metabolites. London: Academic Press, 1971; 446.
Guzmán de Peña D, Aguirre J, Ruiz-Herrera J. Regulation of myco-toxins biosynthesis during sporulation of Aspergelli. En: Miraglia M,Van Equmond H, Berna C, Gilbert J, ed. Mycotoxins and phycotoxinDevelopment in chemistry, toxicology and food safety. USA, 1998;321-26.
Ciegler, A. Mycotoxins: occurrence, chemistry, biological activity.Lloydia 1975; 38: 21-35.
Pier A, Cysewski S, Richard J. Implications of micotoxins in animaldisease. J Am Vet Med Assoc 1980; 176: 719-24.
Kuiper T. Micotoxins: risk assessment and legislation. Toxicol Lett1995;83: 853-59.
Ayres J, mundt J, Sandine W. Microbiology of foods. San Francisco:Freeman, 1980: 708pp.
Blount W. Turkey X disease. J Br Turkey Fed 1961;9: 52-77.
Carnaghan R, Sargeant K. The toxicity of certain groundnut meal topoultry. Veterinary Record 1961; 73: 726-27.
Sargeant K, Sheridan A, Okelly J, Carnaghan R. Toxicology associ-ated with certain samples of groundnut. Nature 1961;192: 1096- 97.
Smith J, Hacking A. Fungal toxicity. The filamentous fungi. London:Arnold EV, 1983: 238-64.
Hussein HS, Brasel JM. Toxicity, metabolism, and impact of myco-toxins on humans and animals. Toxicology 2001;167: 101- 34.
Mirocha C, Pathre S, Christensen, C. Micotoxins: Economic micro-biology. London: Academic Press, 1979: 468-83.
Hesseltine C, Sorrenson W, Smith M. Taxonomic studies of the afla-toxin producing strains in the Aspergillus flavus group. Micología1970: 123-32.
Massey TE, Smith GB, Tam AS. Mechanisms of aflatoxin B1 lungtumorigenesis. Exp Lung Res 2000 ; 26: 673-83.
Maggon KK, Gupta SK, Venkitasubramanian TA. Biosynthesis ofaflatoxins. Bacteriol Rev 1977; 41: 822-55.
Wogan GN, Edwards GS, Newberne PM. Structure activity relation-ships in toxicity and carcinogenicity of aflatoxins and analogs.Cancer Res 1971;31: 1936-42.
Rodríguez J, Patterson C, Potts M, Poneleit C, Beine R. Role ofselected arthropods in the contamination of corn by as Aspergillusflavus measured by aflatoxin production. Alabama: CraftmasterPrinters, 1993: 23-26.
La Gaceta. Número 133. Alcance N0 49. Costa Rica 1999: 4.
La Gaceta. Número 140. Costa Rica 1999: 1.
Molina R. Evaluación de cuatro métodos de muestreo para determi-nar aflatoxinas en maíz almacenado en silos. Boletín TécnicoEstación Experimental Fabio Baudrit M. 1995; 28: 68-75.
Araya C. Normas y Procedimientos del Cáncer en Costa Rica. SanJosé: Ediciones Sanabria, 2001; 88-92.
Sherlock, S. Diseases of the liver and biliary system. Oxford: Blackwell Scientific Publications, 1985; 456-75.
Monto A, Wright TL. The epidemiology and prevention of hepatocel-lular carcinoma. Seminars in Oncology 2001; 28: 441-449.
Sun Z, Lu P, Gail MH, Pee D, Zhang Q, Ming L, et al. Increased riskof hepatocellular carcinoma in male hepatitis B surface antigen car-ries with chronic hepatitis that have delectable urinary aflatoxinmetabolite M1. Hepatology 1999; 30: 379-83.
Ozturk M, Bressac B, Puisieux A, Kew M, Volkmonn M, Bozcall S,et al. P53 Mutation in hepatocellular carcinoma after aflatoxin expo-sure. Lancet 1991;338: 1356-59.
Balanchandran P. Nut milk extrac in aflatoxin B1 induced hepato-celular carcinoma. J Clin Bioch Nut 1998; 25: 63-70.
Barraud L. Enhanced duck hepatitis B virus gene expression follow-ing aflatoxin B1 exposure. Hepatology 1999;29: 1317-23.
Jackson PE, Groopman JD, Johnson PJ. Aflatoxin and liver cancer.Liver tumors. Bailliere s-Clinical-Gastroenterology 1999;13: 545-55.
Wogan GN. Aflatoxin as human carcinogen (editorial).Hepatology1999; 30: 573-74.
Wogan G. Aflatoxins as risk factors for hepatocelular carcinoma inhumans. Cancer Res. 1992;52 : 2114s-2118s.
Sylla A, Diallo MS, Castegnaro J, Wild C. Interactions between hep-atitis B virus infection and exposure to aflatoxins in the developmentof hepatocellular carcinoma: a molecular epidemiological approach.Mutat Res 1999;428: 187-96.
Smela ME, Currier SS, Bailey EA, Essigmann JM. The chemistryand biology of aflatoxin B1: from mutational spectrometry to car-cinogenesis. Carcinogenesis 2001; 22: 535-45.
Hsu IC, Metcalf RA, Sun T, Welsh JA, Wang NJ, Harris CC.Mutational Hotspot in the p53 gene in human hepatocellular carcino-mas. Nature 1991; 350: 427-28.
Ross R, Yuan JM, Yu MC, Wogan G, Qian GS, Tu JT, et al. Urinaryaflatoxin biomarkers and risk of Hepatocellular carcinoma. Lancet.1992; 338: 943-46.
Fauci A, Braunwald E, Isselbacher K, Wilson J, Martin J, Kasper D,Longo D. Harrison. Principios de Medicina interna. 14ª. Edición. McGraw Hill. 1998:660-62.
Betina V: ""Mycotoxins- chemical, biological and environmentalaspects"" Bioactive molecules;: Elsevier Science Publishers; 1989;34-39, 151-169, 175-187, 325-331, 355-361, 393-403, 417-421. 38.Heathcole, JG; Mibbet, JR; ""Aflatoxins: chemical and biologicalaspects"",
Downloads
Published
Issue
Section
License
Copyright (c) 2008 Acta Médica Costarricense
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Los autores que publican en la revista Acta Médica Costarricense pueden distribuir, copiar, remezclar, retocar, leer, descargar, imprimir, buscar y crear a partir de su obra de modo no comercial, indicando los créditos a la revista y sus autores y compartir su obra en las mismas condiciones. Para ello se aplica la licencia Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional(CC BY-NC-SA 4.0)
